A battle between the Arkansas Insurance Department and pharmaceutical manufacturers is heating up with the announcement of a hearing this summer to consider administrative penalties against AstraZeneca Pharmaceuticals LP, the drug manufacturing giant that filed a lawsuit against the state earlier this year over Act 1103 of 2021 the 340B Drug Pricing Nondiscrimination Act.
A battle between the Arkansas Insurance Department and pharmaceutical manufacturers is heating up with the announcement of a hearing this summer to consider administrative penalties against AstraZeneca Pharmaceuticals LP, the drug manufacturing giant that filed a lawsuit against the state earlier this year over Act 1103 of 2021 the 340B Drug Pricing Nondiscrimination Act.
Little Rock Surgery Centers Fight ABCBS Over COVID-era Reimbursements - Arkansas Business — Business News, Real Estate, Law, Construction arkansasbusiness.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from arkansasbusiness.com Daily Mail and Mail on Sunday newspapers.